| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Executive Officer
1 company
Dube Eric M serves as a Chief Executive Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 39 sells. Those positions are worth an estimated $26.5M at current prices.
Historically, Dube Eric M's trades have earned a middling insider score of 56/100 across 23 rated trades. Over a 12-month horizon, 47.4% of those trades were profitable, with an average 12-month return of -17.8%.
The biggest single holding is TVTX (~$26.5M) as Chief Executive Officer. The recent filings there lean toward selling, a net 546,846 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2021 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 9,626 | $31.50 | $303,170.87 | -2.9% | |
| Feb 3, 2021 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 2,406 | $28.91 | $69,557.46 | -1.6% | |
| Feb 2, 2021 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 8,734 | $29.91 | $261,266.72 | -2.8% | |
| Jan 6, 2021 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 6,876 | $26.83 | $184,483.08 | -3.7% | |
| Sep 21, 2020 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 10,805 | $19.28 | $208,319.37 | -5.4% | |
| Jan 8, 2020 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 7,500 | $14.54 | $109,050.00 | -7.8% |